Neuromuscular Blocking Agents and Neuromuscular Dysfunction Acquired in Critical Illness: A Systematic Review and Meta-Analysis

Critical Care Medicine

Volumn 44, Issue 11, 2016, Pages 2070-2078

  Price, David R ^a   Mikkelsen, Mark E ^a   Umscheid, Craig A ^a   Armstrong, Ehrin J ^b,c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

acquired polyneuropathies; agents neuromuscular blocking; critical illness polyneuropathy; neuromuscular blockers; nondepolarizing muscle relaxants; polyneuropathy

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT;

CRITICAL ILLNESS; DISEASE ASSOCIATION; HUMAN; INTENSIVE CARE UNIT; MUSCLE WEAKNESS; MYOPATHY; NEUROMUSCULAR DISEASE; OBSERVATIONAL STUDY; POLYNEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; META ANALYSIS; MUSCLE DISEASE;

CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; MUSCLE WEAKNESS; MUSCULAR DISEASES; NEUROMUSCULAR BLOCKING AGENTS; POLYNEUROPATHIES;

EID: 84991670286     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001839     Document Type: Review

References (42)

1. Greenberg SB, Vender J: The use of neuromuscular blocking agents in the ICU: Where are we now? Crit Care Med 2013; 41:1332-1344
2. Vender JS, Szokol JW, Murphy GS, et al: Sedation, analgesia, and neuromuscular blockade in sepsis: An evidence-based review. Crit Care Med 2004; 32:S554-S561
3. Gainnier M, Roch A, Forel JM, et al: Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004; 32:113-119
4. Papazian L, Forel JM, Gacouin A, et al; ACURASYS Study Investigators: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363:1107-1116
5. Schweickert WD, Hall J: ICU-acquired weakness. Chest 2007; 131:1541-1549
6. de Jonghe B, Lacherade JC, Sharshar T, et al: Intensive care unitacquired weakness: Risk factors and prevention. Crit Care Med 2009; 37:S309-S315
7. Stevens RD, Dowdy DW, Michaels RK, et al: Neuromuscular dysfunction acquired in critical illness: A systematic review. Intensive Care Med 2007; 33:1876-1891
8. Bednarík J, Vondracek P, Dusek L, et al: Risk factors for critical illness polyneuromyopathy. J Neurol 2005; 252:343-351
9. Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL, et al: Critical illness polyneuropathy: Risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001; 27:1288-1296
10. Garnacho-Montero J, Amaya-Villar R, García-Garmendía JL, et al: Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 2005; 33:349-354
11. Leijten FS, De Weerd AW, Poortvliet DC, et al: Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 1996; 22:856-861
12. Derde S, Hermans G, Derese I, et al: Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Crit Care Med 2012; 40:79-89
13. Brunello AG, Haenggi M, Wigger O, et al: Usefulness of a clinical diagnosis of ICU-acquired paresis to predict outcome in patients with SIRS and acute respiratory failure. Intensive Care Med 2010; 36:66-74
14. De Jonghe B, Sharshar T, Lefaucheur JP, et al; Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation: Paresis acquired in the intensive care unit: A prospective multicenter study. JAMA 2002; 288:2859-2867
15. de Letter MA, Schmitz PI, Visser LH, et al: Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001; 29:2281-2286
16. Puthucheary Z, Rawal J, Ratnayake G, et al: Neuromuscular blockade and skeletal muscle weakness in critically ill patients: Time to rethink the evidence? Am J Respir Crit Care Med 2012; 185:911-917
17. Alhazzani W, Alshahrani M, Jaeschke R, et al: Neuromuscular blocking agents in acute respiratory distress syndrome: A systematic review and meta-analysis of randomized controlled trials. Crit Care 2013; 17:R43
18. Higgins JPT, Green S (Eds): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. London, United Kingdom. Available at: http://www.cochrane-handbook.org. Accessed July 15, 2015
19. De Jonghe B, Bastuji-Garin S, Durand MC, et al; Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation: Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med 2007; 35:2007-2015
20. Fan E, Dowdy DW, Colantuoni E, et al: Physical complications in acute lung injury survivors: A two-year longitudinal prospective study. Crit Care Med 2014; 42:849-859
21. Thiele RI, Jakob H, Hund E, et al: Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery'. Thorac Cardiovasc Surg 2000; 48:145-150
22. De Jonghe B, Sharshar T, Hopkinson N, et al: Paresis following mechanical ventilation. Curr Opin Crit Care 2004; 10:47-52
23. Penuelas O, Fernando F-V, Eddy F, et al: Incidence and Outcome of Patients Diagnosed of ICU-Acquired Weakness. American Thoracic Society International Conference. Philadelphia, Pennsylvania, American Thoracic Society; 2013
24. Leijten FS, Harinck-de Weerd JE, Poortvliet DC, et al: The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995; 274:1221-1225
25. Ali NA, O'Brien JM Jr, Hoffmann SP, et al; Midwest Critical Care Consortium: Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008; 178:261-268
26. Bednarík J, Vondracek P, Dusek L, et al: Risk factors for critical illness polyneuromyopathy. J Neurol 2005; 252:343-351
27. Nanas S, Kritikos K, Angelopoulos E, et al: Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol Scand 2008; 118:175-181
28. Fletcher SN, Kennedy DD, Ghosh IR, et al: Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003; 31:1012-1016
29. Price D, Kenyon NJ, Stollenwerk N: A fresh look at paralytics in the critically ill: Real promise and real concern. Ann Intensive Care 2012; 2:43
30. Steingrub JS, Lagu T, Rothberg MB, et al: Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis. Crit Care Med 2014; 42:90-96
31. Douglass JA, Tuxen DV, Horne M, et al: Myopathy in severe asthma. Am Rev Respir Dis 1992; 146:517-519
32. Leatherman JW, Fluegel WL, David WS, et al: Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996; 153:1686-1690
33. Behbehani NA, Al-Mane F, D'yachkova Y, et al: Myopathy following mechanical ventilation for acute severe asthma: The role of muscle relaxants and corticosteroids. Chest 1999; 115:1627-1631
34. Bolton CF, Gilbert JJ, Hahn AF, et al: Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984; 47:1223-1231
35. Hermans G, Wilmer A, Meersseman W, et al: Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007; 175:480-489
36. Hermans G, Van Mechelen H, Clerckx B, et al: Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med 2014; 190:410-420
37. Amaya-Villar R, Garnacho-Montero J, García-Garmendía JL, et al: Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 2005; 31:157-161
38. Verheul GA, de Jongh-Leuvenink J, Op de Coul AA, et al: Tumor necrosis factor and interleukin-6 in critical illness polyneuromyopathy. Clin Neurol Neurosurg 1994; 96:300-304
39. Perez-Molto H: Muscular Relaxants and Critical Illness Myopathy. European Society of Intensive Care Medicine 24th Annual Congress. Berlin, German; 2011
40. Needham DM, Wozniak AW, Hough CL, et al; National Institutes of Health NHLBI ARDS Network: Risk factors for physical impairment after acute lung injury in a national, multicenter study. Am J Respir Crit Care Med 2014; 189:1214-1224
41. Stevens RD, Marshall SA, Cornblath DR, et al: A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009; 37:S299-S308
42. Coakley JH, Nagendran K, Honavar M, et al: Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 1993; 19:323-328